These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 28823931)
1. Abnormal striatal plasticity in a DYT11/SGCE myoclonus dystonia mouse model is reversed by adenosine A2A receptor inhibition. Maltese M; Martella G; Imbriani P; Schuermans J; Billion K; Sciamanna G; Farook F; Ponterio G; Tassone A; Santoro M; Bonsi P; Pisani A; Goodchild RE Neurobiol Dis; 2017 Dec; 108():128-139. PubMed ID: 28823931 [TBL] [Abstract][Full Text] [Related]
2. Alteration of striatal dopaminergic neurotransmission in a mouse model of DYT11 myoclonus-dystonia. Zhang L; Yokoi F; Parsons DS; Standaert DG; Li Y PLoS One; 2012; 7(3):e33669. PubMed ID: 22438980 [TBL] [Abstract][Full Text] [Related]
3. Functional and Molecular Properties of DYT-SGCE Myoclonus-Dystonia Patient-Derived Striatal Medium Spiny Neurons. Kutschenko A; Staege S; Grütz K; Glaß H; Kalmbach N; Gschwendtberger T; Henkel LM; Heine J; Grünewald A; Hermann A; Seibler P; Wegner F Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808167 [TBL] [Abstract][Full Text] [Related]
4. Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse models. Yokoi F; Dang MT; Zhou T; Li Y Hum Mol Genet; 2012 Feb; 21(4):916-25. PubMed ID: 22080833 [TBL] [Abstract][Full Text] [Related]
5. Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. Napolitano F; Pasqualetti M; Usiello A; Santini E; Pacini G; Sciamanna G; Errico F; Tassone A; Di Dato V; Martella G; Cuomo D; Fisone G; Bernardi G; Mandolesi G; Mercuri NB; Standaert DG; Pisani A Neurobiol Dis; 2010 Jun; 38(3):434-45. PubMed ID: 20227500 [TBL] [Abstract][Full Text] [Related]
6. The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease. Tozzi A; de Iure A; Di Filippo M; Tantucci M; Costa C; Borsini F; Ghiglieri V; Giampà C; Fusco FR; Picconi B; Calabresi P J Neurosci; 2011 Feb; 31(5):1850-62. PubMed ID: 21289195 [TBL] [Abstract][Full Text] [Related]
7. Abnormal nuclear envelope in the cerebellar Purkinje cells and impaired motor learning in DYT11 myoclonus-dystonia mouse models. Yokoi F; Dang MT; Yang G; Li J; Doroodchi A; Zhou T; Li Y Behav Brain Res; 2012 Feb; 227(1):12-20. PubMed ID: 22040906 [TBL] [Abstract][Full Text] [Related]
9. Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Martella G; Tassone A; Sciamanna G; Platania P; Cuomo D; Viscomi MT; Bonsi P; Cacci E; Biagioni S; Usiello A; Bernardi G; Sharma N; Standaert DG; Pisani A Brain; 2009 Sep; 132(Pt 9):2336-49. PubMed ID: 19641103 [TBL] [Abstract][Full Text] [Related]
10. Role of major and brain-specific Sgce isoforms in the pathogenesis of myoclonus-dystonia syndrome. Xiao J; Vemula SR; Xue Y; Khan MM; Carlisle FA; Waite AJ; Blake DJ; Dragatsis I; Zhao Y; LeDoux MS Neurobiol Dis; 2017 Feb; 98():52-65. PubMed ID: 27890709 [TBL] [Abstract][Full Text] [Related]
11. Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia. Sciamanna G; Ponterio G; Tassone A; Maltese M; Madeo G; Martella G; Poli S; Schirinzi T; Bonsi P; Pisani A Neuropharmacology; 2014 Oct; 85():440-50. PubMed ID: 24951854 [TBL] [Abstract][Full Text] [Related]
12. Blockade of adenosine A Silva AC; Lemos C; Gonçalves FQ; Pliássova AV; Machado NJ; Silva HB; Canas PM; Cunha RA; Lopes JP; Agostinho P Neurobiol Dis; 2018 Sep; 117():72-81. PubMed ID: 29859867 [TBL] [Abstract][Full Text] [Related]
13. Cortical neuronal hyperexcitability and synaptic changes in SGCE mutation-positive myoclonus dystonia. Sperandeo A; Tamburini C; Noakes Z; de la Fuente DC; Keefe F; Petter O; Plumbly W; Clifton NE; Li M; Peall KJ Brain; 2023 Apr; 146(4):1523-1541. PubMed ID: 36204995 [TBL] [Abstract][Full Text] [Related]
14. Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models. Li W; Silva HB; Real J; Wang YM; Rial D; Li P; Payen MP; Zhou Y; Muller CE; Tomé AR; Cunha RA; Chen JF Neurobiol Dis; 2015 Jul; 79():70-80. PubMed ID: 25892655 [TBL] [Abstract][Full Text] [Related]
15. The neurophysiological features of myoclonus-dystonia and differentiation from other dystonias. Popa T; Milani P; Richard A; Hubsch C; Brochard V; Tranchant C; Sadnicka A; Rothwell J; Vidailhet M; Meunier S; Roze E JAMA Neurol; 2014 May; 71(5):612-9. PubMed ID: 24638021 [TBL] [Abstract][Full Text] [Related]
16. Motor Deficits Coupled to Cerebellar and Striatal Alterations in Ube3a Moreira-de-Sá A; Gonçalves FQ; Lopes JP; Silva HB; Tomé ÂR; Cunha RA; Canas PM Mol Neurobiol; 2021 Jun; 58(6):2543-2557. PubMed ID: 33464534 [TBL] [Abstract][Full Text] [Related]
17. Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia. Martella G; Maltese M; Nisticò R; Schirinzi T; Madeo G; Sciamanna G; Ponterio G; Tassone A; Mandolesi G; Vanni V; Pignatelli M; Bonsi P; Pisani A Neurobiol Dis; 2014 May; 65():124-32. PubMed ID: 24503369 [TBL] [Abstract][Full Text] [Related]
18. Hereditary Myoclonus Dystonia: A Novel Coughlin DG; Bardakjian TM; Spindler M; Deik A Tremor Other Hyperkinet Mov (N Y); 2018; 8():547. PubMed ID: 29607243 [TBL] [Abstract][Full Text] [Related]
19. Screening for SGCE mutations in Moroccan sporadic patients with Myoclonus-Dystonia syndrome. Rachad L; El Otmani H; Karkar A; El Moutawakil B; El Kadmiri N; Nadifi S Neurosci Lett; 2019 Jun; 703():1-4. PubMed ID: 30849405 [TBL] [Abstract][Full Text] [Related]